Next-Gen Trials: Wearables, AI Breast Biomarkers, Blockchain eConsent
A patient's patch, a radiologist's AI nudge, and a blockchain-stamped consent: stories from 2024–2025 trials where wearables, AI breast biomarkers, eConsent, and mobile monitoring changed outcomes and trust.
Robert Maxwell
Oct 07, 2025
stroke wearable diagnostics
breast cancer imaging
psilocybin clinical research
GLP-1 obesity trials